Get started
IDEXX LABIDEXX LABIDEXX LAB

IDEXX LAB

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast

1IDXX chart


Full chart

1IDXX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪33.62 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
39.8
Basic EPS (TTM)
10.1 EUR
Net income (FY)
‪857.66 M‬ EUR
Revenue (FY)
‪3.76 B‬ EUR
Shares float
‪80.20 M‬
Beta (1Y)
0.74

Employees


Employees (FY)
‪11 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪342.26 K‬ EUR
Net income / Employee (1Y)
‪77.97 K‬ EUR

About IDEXX Laboratories, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Jonathan J. Mazelsky
Website
idexx.com
Headquarters
Westbrook
Founded
1983
FIGI
BBG01TNWX841
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1IDXX news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as 1IDXX.

Frequently Asked Questions


The current price of 1IDXX is 414.0 EUR — it has increased by 8.58% in the past 24 hours. Watch IDEXX LAB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange IDEXX LAB stocks are traded under the ticker 1IDXX.
1IDXX stock has risen by 8.52% compared to the previous week, the month change is a 8.52% rise, over the last year IDEXX LAB has showed a 8.52% increase.
We've gathered analysts' opinions on IDEXX LAB future price: according to them, 1IDXX price has a max estimate of 501.45 EUR and a min estimate of 407.54 EUR. Watch 1IDXX chart and read a more detailed IDEXX LAB stock forecast: see what analysts think of IDEXX LAB and suggest that you do with its stocks.
1IDXX reached its all-time high on May 2, 2025 with the price of 414.0 EUR, and its all-time low was 381.3 EUR and was reached on Apr 30, 2025. View more price dynamics on 1IDXX chart.
See other stocks reaching their highest and lowest prices.
1IDXX stock is 7.90% volatile and has beta coefficient of 0.74. Track IDEXX LAB stock price on the chart and check out the list of the most volatile stocks — is IDEXX LAB there?
Yes, you can track IDEXX LAB financials in yearly and quarterly reports right on TradingView.
IDEXX LAB is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
1IDXX earnings for the last quarter are 2.74 EUR per share, whereas the estimation was 2.63 EUR resulting in a 3.93% surprise. The estimated earnings for the next quarter are 2.88 EUR per share. See more details about IDEXX LAB earnings.
IDEXX LAB revenue for the last quarter amounts to ‪922.89 M‬ EUR, despite the estimated figure of ‪921.66 M‬ EUR. In the next quarter, revenue is expected to reach ‪939.57 M‬ EUR.
1IDXX net income for the last quarter is ‪224.32 M‬ EUR, while the quarter before that showed ‪208.80 M‬ EUR of net income which accounts for 7.43% change. Track more IDEXX LAB financial stats to get the full picture.
No, 1IDXX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 4, 2025, the company has ‪11 K‬ employees. See our rating of the largest employees — is IDEXX LAB on this list?
Like other stocks, 1IDXX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IDEXX LAB stock right from TradingView charts — choose your broker and connect to your account.